(416) 546-0675 info@torontoketamineclinic.com
0 Items
Toronto Ketamine Clinic | IV Ketamine Treatment in Toronto and Surrounding Areas
  • Home
  • Our Team
  • Our Programs
    • IV Ketamine Program
    • Intranasal Ketamine program
    • KAP Program
    • Special Programs
      • Veterans
      • First Responders
  • Resources
    • Our Treatment Process
    • Testimonials
    • FAQ
    • Videos
    • Research
    • Treatment Financing
  • Referral Form
    • Online Referral
    • Manual Referral
    • Inclusion and Exclusion Criteria
  • Contact Us
Select Page

Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments

by admin | Jan 21, 2021 | IV Ketamine

Bashkim Kadriu, Laura Musazzi, Ioline D Henter, Morgan Graves, Maurizio Popoli, Carlos A Zarate, Jr International Journal of Neuropsychopharmacology, Volume 22, Issue 2, February 2019, Pages 119–135, https://doi.org/10.1093/ijnp/pyy094 Abstract The underlying...

Recent Posts

  • Newsletter: Ketamine and BDNF what’s the connection
  • Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
  • Ketamine for Depression: The Most Important Advance in Field in 50 Years?

Recent Comments

    Archives

    • October 2024
    • January 2021
    • July 2019

    Categories

    • IV Ketamine

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Facebook
    • Instagram
    • LinkedIn
    • Facebook
    • X
    • RSS
    © 2024 Copyright by Toronto Ketamine Clinic. All rights reserved. Marketing by M.Ad | Privacy Policy| Cancellation Policy